Consuming the equivalent of one can of soda per day caused mice predisposed to colon cancer to develop larger tumors, according to a recent study.
The study, published in the print issue of Science, shows how high-fructose corn syrup fuels the growth of colon tumors in these mice and demonstrated a potential strategy to block this excess tumor growth. Though more study is needed to demonstrate whether high-fructose corn syrup promotes colon tumor growth in humans, the findings might have implications for cancer treatment or prevention.
"The study shows that colorectal polyps feed on high fructose corn syrup and explains the molecular mechanism by which this drives the growth of the tumor," said co-senior author. "While our work was conducted in mice, our findings build on mounting evidence that sugar fuels cancer growth."
Investigators say that, based on their findings, people with colon cancer or those at high risk should avoid sugary drinks.
"If you are predisposed to getting polyps, you should not be drinking any sugar-sweetened beverages," said lead author. "If you have colorectal cancer, you could be feeding your tumor by drinking high-fructose corn syrup."
Consumption of soda and other beverages sweetened with high-fructose corn syrup has increased dramatically since the 1980s, the investigators said. During that same period, rates of obesity and metabolic syndrome, along with colorectal cancer among young and middle-aged adults, have also risen. Observational studies suggest people who eat more sugar-sweetened foods and those who have obesity have a higher risk of colon cancer. But it has been hard to disentangle the effects of diet and complex conditions like obesity in colon cancer.
Other observational studies have linked diets high in processed meat and low in fiber to increased colon cancer risk, while high-fiber diets loaded with fruits and vegetables and low in red meat have been associated with reduced risk. Though these types of studies can't prove that diet causes colon cancer, there are good reasons to suspect it might contribute.
Now, researchers provide more direct evidence that sugar promotes colon tumor growth. To do this, they squirted a small dose of high-fructose corn syrup each day for eight to nine weeks into the mouths of mice genetically engineered to develop colon tumors. This dose is the mouse equivalent of drinking one soda per day, which about half of Americans do, the lead author said. These mice did not become obese or develop metabolic syndrome. The investigators then compared the tumors that developed in the sugar-fed mice with tumors in mice with the same predisposition to colon tumors but no added sugar in their diet. They found that the sugar-fed mice developed more large tumors compared with the control mice.
"We were not able to show that giving high-fructose syrup causes new tumors because these mice develop tumors even on normal diets free of added sugar," the lead author cautioned. "But when you give them this additional sugar, the tumors grow much bigger."
To understand why, they looked at what happens when mice are fed high-fructose corn syrup. Consuming the sweetener delivers an excess of both glucose and fructose to the colon of the mice. By using isotope-labeled sugars, the team showed colon tumors readily take in both sugars. An enzyme called ketohexokinase (KHK) changes the fructose into fructose-1-phosphate, which makes it easier for the tumor to use glucose for energy. This also promotes the production of fats necessary for tumors to grow. Both the fats and the fructose-1-phosphate promote more tumor growth. Preliminary studies on the effects of added table sugar, also known as sucrose, led to a similar degree of glucose and fructose exposure in the gut; the investigators speculate that sucrose could also drive tumor growth in this model.
"We expect that consuming beverages or processed foods with added sucrose is likely to have the same effect as consuming drinks with high-fructose corn syrup, since sucrose has a similar composition of fructose and glucose to high-fructose corn syrup," the senior author said.
Deleting the gene for KHK or a gene called fatty acid synthase, which is responsible for producing fats that are essential for making the membranes that surround new cancer cells, in mice genetically engineered to develop colon tumors prevents the tumor growth-promoting effects of high-fructose corn syrup.
This may suggest that drugs targeting KHK or fat production in tumor cells may help reverse the tumor-growing effects of these sugars in people. One potential way to determine whether this would be effective is to randomize patients to receive a KHK-blocking drug, which is currently in phase 2 clinical trials for fatty liver disease. Another approach would be to test whether a very low-sugar diet, like the ketogenic diet, slows tumor growth, the lead said. The authors have created a ketogenic diet that is less than 3 percent carbohydrate and has no sugar, which they thinks could be helpful for patients undergoing cancer therapy. The lead cautioned that the dietary approach would work best with treatments such as chemotherapy or radiation.
"It's the ability of diet to enhance traditional therapy that I believe holds the most promise," the lead said.
https://news.weill.cornell.edu/news/2019/03/high-fructose-corn-syrup-promotes-colon-tumor-growth-in-mice
http://science.sciencemag.org/content/363/6433/1345
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fhigh-fructose-corn&filter=22
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
'Jumping genes' drive many cancers
Read more
Gene duplications could be fixed with CRISPR/CAS9 and MMEJ repair m…
Read more
Normal mutations in human livers can promote tissue regeneration
Read more
Poverty leaves a mark on our genes
Read more
ALS progression at the genetic and cellular level
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar